Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Autonomic dysfunction in multiple sclerosis.
Using multiple imputation to efficiently correct cerebral MRI whole brain lesion and atrophy data in patients with multiple sclerosis.
Processing speed and working memory training in multiple sclerosis: A double-blind randomized controlled pilot study.
Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis.
Timing of cigarette smoking as a risk factor for multiple sclerosis.
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.
Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis.
Evaluation of Cytokines in Multiple Sclerosis Patients Treated with Mesenchymal Stem Cells.
Th17 cells in central nervous system autoimmunity.
Anticomplement therapy.
Are there evidence-based dietary interventions for multiple sclerosis?
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.
Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
Telehealth weight management intervention for adults with physical disabilities: a randomized controlled trial.
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review.
Diffusion-weighted imaging and demyelinating diseases: new aspects of an old advanced sequence.
[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
Demyelinating disease: NMO spectrum disorders: clinical or molecular classification?
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life.
Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis.
Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.
Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review.
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
Pages
« first
‹ previous
…
476
477
478
479
480
481
482
483
484
…
next ›
last »